TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Equip your practice to address today's most common skin condition
Acne affects up to 50 million Americans annually, making it the most common skin condition in the United States1. Unfortunately, breakouts can occur at any stage of life—clinical studies have shown that 40-55% of adults aged 20 to 40 are diagnosed with low-grade acne and oily skin2. Aside from the physical effects of acne, the condition can also have an impact on emotional and psychological well-being.
This is exactly why medical providers and aestheticians have a lot to gain by offering an effective acne treatment. With that in mind, one powerful solution is to use an acne treatment machine such as the Venus Versa™. The AC Dual IPL applicator combines blue and red light delivered simultaneously with each pulse. The blue light targets and destroys acne-causing bacteria, while red light reduces inflammation and promotes faster healing.3
For a doctor or aesthetician looking for a safe and effective acne treatment device, the Venus Versa™ is a legitimate solution. With the right machine for acne, you can effectively help to turn your patients' lives around. While traditional treatments focus on either the cause or the visible symptoms of the skin condition, Venus Concept has developed an acne treatment device that targets both, resulting in greater clinical outcomes and higher patient satisfaction. In combination with Venus Concept’s industry-unique subscription model, the Venus Versa™ acne treatment machine is designed to enable a higher return on ownership to further increase the success of your practice.
Our organization is known for our easy-to-use, non-invasive technologies that serve customers in a safe and effective manner. Our innovative professional acne treatment machines help you grow your patient base all while providing services that are in line with the needs of the modern aesthetic customer. If you have additional questions about Venus Concept’s aesthetic acne treatment options, or on how we may be able to grow your business, feel free to reach out to us at any time.
A versatile multi-applicator platform with three different, highly effective technologies in one workstation to address many of today's most challenging aesthetic concerns. The AC Dual applicator uses IPL to simultaneously address both the cause and visible symptoms of acne*.
Treat acne vulgaris quickly and effectively by destroying P. acnes bacteria while accelerating healing of existing inflammation.
Devices that offer acne treatments: Venus Versa™
Results after: 6 treatments
Courtesy of Rosenberg Plastic Surgery
INDICATIONS FOR USE:
*Venus Versa™ is cleared by the FDA as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The NanoFractional RF™ (Viva) applicator is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.↩
REFERENCES:
To book a consultation or a demo, please contact us by clicking the button below and a representative will reach out to you directly.
For more information call: (888) 907-0115 // info@venusconcept.com // 1880 N Commerce Parkway, Suite 2, Weston, FL, 33326 United States
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite.
Venus Versa™ is cleared by the FDA as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The NanoFractional RF™ (Viva) applicator is cleared by the FDA for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators.
Venus Velocity™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae, for all Fitzpatrick skin types.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Freeze Plus™ is a non-invasive device cleared by the FDA for use in dermatologic and general surgical procedures for females for the treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV, using the DiamondPolar™ and OctiPolar™ applicators.
Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. The treatment of these conditions will lead to the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Epileve™ is cleared by the FDA for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs
re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More